CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Read the latest news stories and press releases from HCA Healthcare UK in London, Birmingham and Manchester.
HCA Healthcare UK’s The Harborne Hospital, has become the first private hospital provider in Birmingham to offer renal denervation (RDN) for people with resistant hypertension (high blood pressure).
HCA UK’s The Harborne Hospital in Birmingham has become the first facility in the West Midlands to treat a lung cancer patient using bispecific antibody therapy, a significant advancement in the treatment of solid tumours, highlighting the hospital’s growing role in cutting-edge cancer care.
Leading private healthcare provider HCA Healthcare UK has announced that it is offering amyloid-targeting therapies for patients diagnosed with early-stage Alzheimer's disease. The therapies available include lecanemab and donanemab - the first two disease-modifying treatments for Alzheimer’s disease licensed for use in Great Britain.